NYU Comprehensive Epilepsy Center — New York, New York

NYU Comprehensive Epilepsy Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

NYU Comprehensive Epilepsy Center has participated in 14 clinical trials with 2 currently active.

Therapeutic areas: Partial Epilepsy, Epilepsy, Lennox Gastaut Syndrome (LGS).

Sponsors: SK Life Science, Inc., The Epilepsy Study Consortium, Takeda.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Comprehensive Epilepsy Center?

NYU Comprehensive Epilepsy Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Comprehensive Epilepsy Center conducted?

NYU Comprehensive Epilepsy Center has 14 clinical trials on record, with 2 currently active. Their work covers Partial Epilepsy, Epilepsy, Lennox Gastaut Syndrome (LGS).

Is NYU Comprehensive Epilepsy Center accredited by Crixeo Health?

Yes — NYU Comprehensive Epilepsy Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NYU Comprehensive Epilepsy Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.